查看购物车
  • Traditional Chinese
  • Japanese
  • Korean
30个国家的体外诊断(IVD)市场:2025年
市场调查报告书
商品编码
1690998

30个国家的体外诊断(IVD)市场:2025年

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025
出版日期: | 出版商: Kalorama Information | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

本报告对美国、中国、德国、英国、沙乌地阿拉伯、印度、阿联酋、法国、越南和土耳其等 30 个主要国家的体外诊断 (IVD) 市场进行了全面分析。它及时洞察不断发展的全球体外诊断市场，包括详细的市场规模、2029 年和 2030 年的预测以及截至 2025 年的季度更新。

重要的IVD领域详细的预测

  • 血库筛检 - 免疫学
  • 凝血功能 PT/常规
  • 紧急医疗护理（核心实验室）
  • 普通化学测试
  • 血液学
  • 组织学
  • 免疫分析微量
  • 免疫测定 - 非微量
  • 微生物学-ID/AST
  • 分子检验- 其他
  • 分子血流/HAI
  • 分子HIV/肝炎
  • 分子呼吸系统
  • POC重症加护
  • POC粪便潜血
  • POC葡萄糖(全部)
  • POC感染疾病(全部)
  • POC妊娠·不孕
  • 其他的IVD
  • 其他的POC

目录

第1章 全球IVD市场

  • IVD市场需求与成长
  • 范围与调查手法
  • 市场区隔

第2章 美国的IVD市场

  • 美国的IVD市场概要
  • 美国的IVD新闻

第3章 德国的IVD市场

  • 德国的IVD市场概要
  • 德国的IVD新闻

第4章 中国

  • 中国的IVD市场概要
  • 中国的IVD新闻

第5章 日本的IVD市场

  • 日本的IVD市场概要
  • 日本的IVD新闻

第6章 法国

  • 法国的IVD市场概要
  • 法国的IVD新闻

第7章 英国

  • 英国的IVD市场概要
  • 英国的IVD新闻

第8章 义大利

  • 义大利的IVD市场概要
  • 义大利的IVD新闻

第9章 加拿大

  • 加拿大的IVD市场概要
  • 加拿大的IVD新闻

第10章 西班牙

  • 西班牙的IVD市场概要
  • 西班牙的IVD新闻

第11章 澳洲

  • 澳洲的IVD市场概要
  • 澳洲的IVD新闻

第12章 巴西

  • 巴西的IVD市场概要

第13章 印度

  • 印度的IVD市场概要
  • 印度的IVD新闻

第14章 俄罗斯

  • 俄罗斯的IVD市场概要

第15章 荷兰

  • 荷兰的IVD市场概要
  • 荷兰的IVD新闻

第16章 瑞士

  • 瑞士的IVD市场概要
  • 瑞士的IVD新闻

第17章 波兰

  • 波兰的IVD市场概要

第18章 土耳其

  • 土耳其的IVD市场概要

第19章 墨西哥

  • 墨西哥的IVD市场概要

第20章 瑞典

  • 瑞典的IVD市场概要

第21章 比利时

  • 比利时的IVD市场概要

第22章 奥地利

  • 奥地利的IVD市场概要

第23章 沙乌地阿拉伯

  • 沙乌地阿拉伯的IVD市场概要

第24章 韩国

  • 韩国的IVD市场概要
  • 韩国的IVD新闻

第25章 埃及

  • 埃及的IVD市场概要

第26章 罗马尼亚

  • 罗马尼亚的IVD市场概要

第27章 南非

  • 南非的IVD市场概要

第28章 印尼

  • 印尼的IVD市场概要

第29章 智利

  • 智利的IVD市场概要

第30章 阿拉伯联合大公国

  • 阿拉伯联合大公国的IVD概要
  • 阿拉伯联合大公国的IVD新闻

第31章 越南

  • 越南的IVD市场概要

附录:30个国家的IVD市场区隔全体

简介目录
Product Code: 25-020KA

Kalorama Information's "30-Country IVD Market Atlas, 2025" provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

  • Blood Bank Screening - Immunos
  • Coagulation PT/Routine
  • Critical Care (core lab)
  • General Chemistries
  • Hematology
  • Histology
  • Immunoassays - Micro
  • Immunoassays - Non-Micro
  • Microbiology - ID/AST
  • Molecular - Other
  • Molecular Bloodstream/HAI
  • Molecular HIV & Hepatitis
  • Molecular Respiratory
  • POC Critical Care
  • POC Fecal Occult
  • POC Glucose (all)
  • POC Infectious Disease (all)
  • POC Pregnancy & Fertility
  • Other IVD
  • Other POC

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama's "30-Country IVD Market Atlas, 2025" consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report's quarterly updates via Kalorama's Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

TABLE OF CONTENTS

CHAPTER 1: WORLDWIDE IVD MARKET

  • IVD MARKET DEMAND AND GROWTH
  • SCOPE AND METHODOLOGY
  • MARKET SEGMENTATION
    • Country Atlas Scope
      • Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2024
      • Table 1-2: Global IVD Market by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
      • Figure 1-1: Global IVD Market by Leading Countries, Estimated 2024 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
      • Figure 1-2: Global IVD Market by Leading Countries, Estimated 2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

CHAPTER 2: U.S. IVD MARKET

  • UNITED STATES IVD MARKET OVERVIEW
    • Table 2-1: U.S. IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 2-1: U.S. IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 2-2: U.S. IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN THE UNITED STATES

CHAPTER 3: GERMANY IVD MARKET

  • GERMANY IVD MARKET OVERVIEW
    • Table 3-1: Germany IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 3-1: Germany IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 3-2: Germany IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN GERMANY

CHAPTER 4: CHINA

  • CHINA IVD MARKET OVERVIEW
    • Table 4-1: China IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 4-1: China IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 4-2: China IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN CHINA

CHAPTER 5: JAPAN IVD MARKET

  • JAPAN IVD MARKET OVERVIEW
    • Table 5-1: Japan IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 5-1: Japan IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 5-2: Japan IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN JAPAN

CHAPTER 6: FRANCE

  • FRANCE IVD MARKET OVERVIEW
    • Table 6-1: France IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 6-1: France IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 6-2: France IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN FRANCE

CHAPTER 7: UNITED KINGDOM

  • UNITED KINGDOM IVD MARKET OVERVIEW
    • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 7-1: United Kingdom IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 7-2: United Kingdom IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN THE UNITED KINGDOM

CHAPTER 8: ITALY

  • ITALY IVD MARKET OVERVIEW
    • Table 8-1: Italy IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 8-1: Italy IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 8-2: Italy IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN ITALY

CHAPTER 9: CANADA

  • CANADA IVD MARKET OVERVIEW
    • Table 9-1: Canada IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 9-1: Canada IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 9-2: Canada IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN CANADA

CHAPTER 10: SPAIN

  • SPAIN IVD MARKET OVERVIEW
    • Table 10-1: Spain IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 10-1: Spain IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 10-2: Spain IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN SPAIN

CHAPTER 11: AUSTRALIA

  • AUSTRALIA IVD MARKET OVERVIEW
    • Table 11-1: Australia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 11-1: Australia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 11-2: Australia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN AUSTRALIA

CHAPTER 12: BRAZIL

  • BRAZIL IVD MARKET OVERVIEW
    • Table 12-1: Brazil IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 12-1: Brazil IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 12-2: Brazil IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 13: INDIA

  • INDIA IVD MARKET OVERVIEW
    • Table 13-1: India IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 13-1: India IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 13-2: India IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN INDIA

CHAPTER 14: RUSSIA

  • RUSSIA IVD MARKET OVERVIEW
    • Table 14-1: Russia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 14-1: Russia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 14-2: Russia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 15: THE NETHERLANDS

  • THE NETHERLANDS IVD MARKET OVERVIEW
    • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 15-1: The Netherlands IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 15-2: The Netherlands IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN THE NETHERLANDS

CHAPTER 16: SWITZERLAND

  • SWITZERLAND IVD MARKET OVERVIEW
    • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 16-1: Switzerland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 16-2: Switzerland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN SWITZERLAND

CHAPTER 17: POLAND

  • POLAND IVD MARKET OVERVIEW
    • Table 17-1: Poland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 17-1: Poland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 17-2: Poland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 18: TURKEY

  • TURKEY IVD MARKET OVERVIEW
    • Table 18-1: Turkey IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 18-1: Turkey IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 18-2: Turkey IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 19: MEXICO

  • MEXICO IVD MARKET OVERVIEW
    • Table 19-1: Mexico IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 19-1: Mexico IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 19-2: Mexico IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 20: SWEDEN

  • SWEDEN IVD MARKET OVERVIEW
    • Table 20-1: Sweden IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 20-1: Sweden IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 20-2: Sweden IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 21: BELGIUM

  • BELGIUM IVD MARKET OVERVIEW
    • Table 21-1: Belgium IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 21-1: Belgium IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 21-2: Belgium IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 22: AUSTRIA

  • AUSTRIA IVD MARKET OVERVIEW
    • Table 22-1: Austria IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 22-1: Austria IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 22-2: Austria IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 23: SAUDI ARABIA

  • SAUDI ARABIA IVD MARKET OVERVIEW
    • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 23-2: Saudi Arabia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 24: SOUTH KOREA

  • SOUTH KOREA IVD MARKET OVERVIEW
    • Table 24-1: South Korea IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 24-1: South Korea IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 24-2: South Korea IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN SOUTH KOREA

CHAPTER 25: EGYPT

  • EGYPT IVD MARKET OVERVIEW
    • Table 25-1: Egypt IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 25-1: Egypt IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 25-2: Egypt IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 26: ROMANIA

  • ROMANIA IVD MARKET OVERVIEW
    • Table 26-1: Romania IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 26-1: Romania IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 26-2: Romania IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 27: SOUTH AFRICA

  • SOUTH AFRICA IVD MARKET OVERVIEW
    • Table 27-1: South Africa IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 27-1: South Africa IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 27-2: South Africa IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 28: INDONESIA

  • INDONESIA IVD MARKET OVERVIEW
    • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 28-1: Indonesia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 28-2: Indonesia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 29: CHILE

  • CHILE IVD MARKET OVERVIEW
    • Table 29-1: Chile IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 29-1: Chile IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 29-2: Chile IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 30: UNITED ARAB EMIRATES

  • UNITED ARAB EMIRATES IVD OVERVIEW
    • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 30-2: United Arab Emirates IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • IVD NEWS IN THE UNITED ARAB EMIRATES

CHAPTER 31: VIETNAM

  • VIETNAM IVD MARKET OVERVIEW
    • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 31-1: Vietnam IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 31-2: Vietnam IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

APPENDIX: 30-COUNTRY IVD SEGMENT TOTALS

  • Table A-1: Blood Bank Screening (Immunos), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-2: Coagulation PT/INR, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-3: Critical Care (core lab), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-4: General Chemistries, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-5: Hematology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-6: Histology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-7: Immunoassays (Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-8: Immunoassays (Non-Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-9: Microbiology (ID/AST), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-10: Molecular Bloodstream/HAI, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-11: Molecular HIV & Hepatitis, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-12: Molecular Respiratory, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-13: Molecular (Other), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-14: POC Critical Care , Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-15: POC Fecal Occult, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-16: POC Glucose (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-17: POC Infectious Disease (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-18: POC Pregnancy & Fertility, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-19: Other IVD, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-20: Other POC, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]